Page last updated: 2024-09-04

docetaxel anhydrous and birinapant

docetaxel anhydrous has been researched along with birinapant in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(birinapant)
Trials
(birinapant)
Recent Studies (post-2010) (birinapant)
12,1103,2166,92074274

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)birinapant (IC50)
Baculoviral IAP repeat-containing protein 2Homo sapiens (human)0.05

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlson, SG; Chen, Z; Eytan, DF; Schiltz, S; Snow, GE; Van Waes, C1

Other Studies

1 other study(ies) available for docetaxel anhydrous and birinapant

ArticleYear
Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC.
    The Laryngoscope, 2015, Volume: 125, Issue:3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Count; Cell Line, Tumor; Cell Proliferation; Dipeptides; Docetaxel; Drug Therapy, Combination; Female; Flow Cytometry; Head and Neck Neoplasms; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Mice; Mitochondrial Proteins; Neoplasms, Experimental; Squamous Cell Carcinoma of Head and Neck; Taxoids; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2015
chemdatabank.com